Mds/aml Research Group

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

1 Citation (Scopus)

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia

Kenealy, M., Hertzberg, M., Benson, W., Taylor, K., Cunningham, I., Stevenson, W., Hiwase, D., Eek, R., Zantomio, D., Jong, S., Wall, M., Blombery, P., Gerber, T., Debrincat, M., Zannino, D. & Seymour, J. F., 31 Mar 2019, In : Haematologica. 104, 4, p. 700-709 10 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Mobilisation strategies for normal and malignant cells

Bik To, L., Levesque, J. P., Herbert, K. E., Winkler, I. G., Bendall, L. J., Hiwase, D., Antonenas, V., Rice, A. M., Gottlieb, D., Mills, A. K., Rasko, J. E., Larsen, S., Beligaswatte, A., Nilsson, S. K., Cooney, J. P., Cambareri, A. C. & Lewis, I. D., 1 Jan 2011, In : Pathology. 43, 6, p. 547-565 19 p.

Research output: Contribution to journalReview article

33 Citations (Scopus)

Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma

Hiwase, D., Bollard, G., Hiwase, S., Bailey, M., Muirhead, J. & Schwarer, A. P., 28 Sep 2007, In : Cytotherapy. 9, 6, p. 539-547 9 p.

Research output: Contribution to journalArticle